---
title: "Viridian Therapeutics (VRDN) Gets a Buy from RBC Capital"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291273573.md"
description: "RBC Capital analyst Lisa Walter maintained a Buy rating on Viridian Therapeutics (VRDN) with a $35 price target, while shares closed at $18.79. Additionally, Wells Fargo's Derek Archila issued a new Buy rating today, contrasting with his previous Hold rating from June 17."
datetime: "2026-06-30T11:15:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291273573.md)
  - [en](https://longbridge.com/en/news/291273573.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291273573.md)
---

# Viridian Therapeutics (VRDN) Gets a Buy from RBC Capital

RBC Capital analyst Lisa Walter maintained a Buy rating on Viridian Therapeutics yesterday and set a price target of $35.00. The company’s shares closed yesterday at $18.79.

### End of Quarter Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

According to TipRanks, Walter is a 4-star analyst with an average return of 10.3% and a 62.71% success rate. Walter covers the Healthcare sector, focusing on stocks such as Viridian Therapeutics, United Therapeutics, and Apellis Pharmaceuticals.

In addition to RBC Capital, Viridian Therapeutics also received a Buy from Wells Fargo’s Derek Archila in a report issued today. However, on June 17, Wells Fargo maintained a Hold rating on Viridian Therapeutics (NASDAQ: VRDN).

### Related Stocks

- [VRDN.US](https://longbridge.com/en/quote/VRDN.US.md)
- [UTHR.US](https://longbridge.com/en/quote/UTHR.US.md)
- [APLS.US](https://longbridge.com/en/quote/APLS.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)

## Related News & Research

- [SEB Asset Management AB Makes New Investment in Viridian Therapeutics, Inc. $VRDN](https://longbridge.com/en/news/293727428.md)
- [Viridian Therapeutics announces FDA approval, launch of Lumvoa](https://longbridge.com/en/news/291022599.md)
- [RBC Capital Reaffirms Their Buy Rating on EssilorLuxottica SA (0OMK)](https://longbridge.com/en/news/294105738.md)
- [RBC Capital Sticks to Their Buy Rating for Woodward (WWD)](https://longbridge.com/en/news/293997281.md)
- [RBC Capital Keeps Their Buy Rating on Banco Santander (BNC)](https://longbridge.com/en/news/294033992.md)